Presentation: fever, chest pain, weight loss, fatigue, weakness, decreased activity, worsening cough, dyspnea, decreased appetite, weight loss, and pain / malignant serosanguineous pleural effusions are common and are often large and recurrent.
Diagnosis (also see SPN below) [NEJM]
CXR (mass, effusion) bronchial narrowing and irregularity, parenchymal infiltration, or atelectasis. Cavitation may be visible in an obstructed area or within a peripheral tumor. Pleural effusions are often associated with infiltrating or peripheral tumors
thoracentesis (60% yield in NSCLC; would be IIIB T4) / pH usu. > 7.3 (< 7.2 worse prognosis) / WBC < 4000 cells/mm3 (< 25% neutrophils; more suggests infection)
CT (chest, head, liver)
bronchoscopy
MRI (its role is evolving)
CT (still debated whether screening is beneficial or cost-effective 3/07)
bone scan
LFT
bronchial biopsy, washings
mediastinoscopy with lymph node biopsy
exploratory thoracotomy required in < 10% of cases to establish the diagnosis (if any evidence of mets, probably no benefit; such as lymph nodes, skin, liver, pleura)
Ddx: foreign bodies, nonsegmental pneumonia, endobronchial and focal pulmonary manifestations of TB, systemic mycoses, autoimmune disease, metastatic disease caused by an extrathoracic primary cancer. Solitary pulmonary nodules are difficult to differentiate.
Metastases to the lungs are common from primary cancers of the breast, colon, prostate, kidney, thyroid, stomach, cervix, rectum, testis, bone and melanoma
Treatment: radiation / chemotherapy (see other sources)
Primary Lung Cancer
Staging: T - location (3 cm cutoff)
N - nodes involved
M - metastases (brain, bone, liver)
CXR: concave (good), convex (bad)
Smokers (85%)
squamous, small cell, adenocarcinoma, large cell
Non-smokers (15%)
⅔ are adenocarcinoma (even most adenocarcinomas are from smoking), bronchoalveolar adenoma, other
Central squamous, small cell, adenocarcinoma (↓)
Peripheral large cell, adenocarcinoma (↑)
Pattern of spread
all types also commonly spread via the lymphatics / large cell also more through bloodstream
Bronchogenic Carcinomas (SCLC vs. NSCLC)
divided into small cell and non-small cell (adenocarcinoma, large cell, squamous cell)
Note: treatment is chemotherapy and/or radiation for SLCL (rarely surgery) and resection (if possible) and/or chemo for NSCLC / 10% of NSCLC develop some form of HOA (Pierre-Marie-Bamberger syndrome) [pic]
Small Cell Carcinoma (SCC) (20%) – central
oat cell / metastases / smoking / often secrete ectopic hormones (SIADH, ACTH) causing symptoms of hypokalemia (ACTH) or hyponatremia (ADH) / hemoptysis uncommon
Associations: Lambert-Eaton syndrome
Treatment: chemotherapy (not resectable) / 20% can be cured if caught very early
Squamous Cell Carcinoma (30%) – central
metastasis uncommon / smoking / PTH-related (PTHrP) hypercalcemia / HOA with clubbing
Adenocarcinoma (35%) – peripheral > central
characteristic HOA w/ clubbing / makes up 70% of lung cancers in non-smokers
Large Cell (10%) – peripheral
smoking / usually spreading through the bloodstream
Bronchoalveolar adenoma – peripheral
not associated with smoking / multifocal origin but often does not extend beyond the lungs / watery, profuse, blood-streaked hemoptysis
Bronchial carcinoid (5%)
benign or malignant / male = female
Complications: may obstruct lumen, frequent bleeding, recurrent pneumonia, pleural pain / carcinoid syndrome (3%)
Course: prolonged / mets (uncommonly) to regional lymph nodes
Pancoast tumor
refers to an apical carcinoma causing pancoast syndrome
Other Lung Tumors
Lymphoma – usually solitary, can be multifocal
Sarcoma – malignant
Carcinosarcoma
Kaposi’s sarcoma (see HIV)
Adenoid cystic .5%
Mucoepidermoid carcinoma .2%
Malignant fibrous histiocytoma
Melanoma
Blastoma
Mucoepidermal
Angiomas – may regress
Squamous papillomatosis – often recur
Benign Tumors
Chondromatous hamartoma
“popcorn” or “bull’s eye” pattern of calcification / cartilage, connective tissue, epithelium
Sclerosing hemangioma
80% female / calcification on X-ray / blood spaces
Horner’s syndrome
invasion of the cervical thoracic sympathetic nerves (paravertebral stellate ganglion) (often by lung cancer)
Findings: enophthalmos, miosis, ptosis, ipsilateral facial anhidrosis, narrowing of palpedral fissure [pic][pic][pic]
Ddx: brainstem or posterior circulation CVA, carotid artery dissection, cavernous sinus thrombosis, trauma, metastatic disease
Pancoast syndrome
infiltration of brachial plexus and neighboring ribs and vertebrae, may involve phrenic nerve / Findings: pain, numbness, and weakness of the affected arm and/or Horner’s syndrome (see above)
Superior vena cava syndrome (SVC syndrome or SVCS)
obstruction of venous drainage dilation of collateral veins in upper chest, neck edema and plethora of face, neck, upper part of the torso, including the breasts; suffusion and edema of the conjunctiva; breathlessness when supine; CNS symptoms (headache, visual distortion, ΔMS, dizziness, syncope); dysphagia, hoarseness
Causes: lung cancer (small cell, squamous cell), other malignant neoplasms (lymphoma, Hodgkin’s disease, small cell carcinoma, squamous cell carcinoma, germ cell tumors, and breast cancer), TB, fungal infections, retrosternal thyroid, aortic aneurysms, fibrosing mediastinitis, benign tumors
Treatment: if airway impaired, may need urgent bronchoscopy with stenting, surgical consultation / if lymphoma strongly suspected, may begin steroids even before tissue diagnosis
Hematogenous metastatic spread to the liver, brain, adrenals, and bone
Paraneoplastic syndromes
hypertrophic pulmonary osteoarthropathy (the best known), clubbing of the fingers and toes and periosteal elevation of the distal parts of long bones occur. All levels of the nervous system may be affected--principally causing encephalopathy, subacute cerebellar degeneration, encephalomyelitis, the
CNS paraneoplastic
60% become symptomatic (CNS-wise) wise before any symptoms from primary tumor occur
can test for variety of antibodies [table]; no specific antibodies are found in 40% (that may change)
may use PET scan or MRI to locate mets or primary [MRI] (note can have false positive on axilla of side of injection of tracer material)
Eaton-Lambert syndrome (see other) and peripheral neuropathy
Paraneoplastic cerebellar degeneration [NEJM]
may present as progressive cerebellar ataxia [table] / 20% have mild memory and cognitive impairment (paraneoplastic limbic encephalitis), new onset seizures (complex partial)
Associated malignancies: small cell lung cancer > breast, ovarian, testicular, Hodgkin’s
MRI: patchy increased T2 without enhancement on T1 distinguishes from brain tumor, other / Purkinje cell dropout in cerebellum shows as atrophy
EEG: focal temporal sharp waves
Labs:
antineuronal nuclear antibody type 1 (ANNA-1, anti-Hu) usu. positive with SCLC
anti-Yo seen with breast, ovarian tumors
anti-Tr, anti-glutamate receptor antibodies
Polymyositis and dermatomyositis
metabolic syndromes due to production of substances with hormonal activity
Small cell carcinomas may secrete ectopic ACTH, resulting in Cushing’s syndrome, or ADH, causing water retention and hyponatremia, and are also associated with the carcinoid syndrome (flushing, wheezing, diarrhea, and cardiac valvular lesions).
Squamous cell carcinomas may secrete parathyroid hormone-like substances that produce hypercalcemia. Other endocrine syndromes associated with primary lung carcinomas include gynecomastia, hyperglycemia, thyrotoxicosis, and skin pigmentation. Hematologic disorders, including thrombocytopenic purpura, leukemoid reaction, myelophthisic anemia, polycythemia, and marantic thrombosis, may also occur.
Findings: gynecomastia, skin pigmentation
Other associations: thyrotoxicosis, TTP, leukemoid reaction, polycythemia, myelophthisic anemia
Single Pulmonary Nodule (SPN)
50% (< 3 cm) prove malignant / coin lesion without surrounding atelectasis or adenopathy
Benign: 80% infectious granulomas, 10% hamartomas, 10% other
Malignant: > 3 cm is probably malignant; most are bronchogenic carcinoma
Ddx: Coccidioides, Histoplasma, Tb, RA, Wegener’s
Bayesian approach pre-test risk of malignancy vs. need for early removal / if patient < 35 yrs, non-smoker, can follow radiographically first
Risk factors: age, smoking, hemoptysis, size, edge characteristics on CT, prior malignancy
Other: carcinogens, travel, endemic mycoses, prior lung disease
Guidelines for following: constantly changing; (~4-8 mm seems to be a size parameter below which the optimal frequency of repeat CT is debated)
CXR: size / growth rate / margin: corona radiata (80-90% malignant)
calcification:
laminated or central granuloma
popcorn hamartoma
diffuse benign
eccentric/stippled malignant
less specific cavitations [CXR], satellite lesions
CT: more sensitive for other lesions, calcifications, guiding TNAB
if thought to be benign ( < 35 yrs, stable for 2 yrs, classic calcification pattern) repeat CXR q 3 months for 1st yr, q 4-6 mo for 2nd year
if thought to be malignant VATS frozen thoracotomy/lobectomy
indeterminate (usually will prove malignant)
PET (18FDG PET scanning): has 95% sensitivity, 75% specificity (also good for demonstrating positive nodes) / false negatives more likely with tumors < 1 cm, bronchoalveolar carcinomas, carcinoid tumors / false positives from inflammation
Bronchoscopy (better for central): sensitivity 80% > 3 cm (50% peripheral) / 2-3 cm (40-60% yield) / < 1.5 cm (10% yield)
Transthoracic needle biopsy (better for peripheral): 80-95% sensitivity, 50-85% specificity; better than bronchoscopy for peripheral lesions
Share with your friends: |